Astellas Pharma Inc. ALPMF
16.86 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
Day range unavailable
11.40 52-week range 18.03
- YTD
- +28.02%
- 1 year
- +52.17%
- Market cap
- 30.23B
- EPS (ttm)
- 1.36
- P/E ratio
- 12.40
- YTD return
- +28.02%
- 1-year return
- +52.17%
- Avg volume
- 5.96K
- Previous close
- 16.86
- 52-week range
- 11.40 – 18.03
- Earnings date
- Nov 4, 2026
5D +0.86 (+5.37%)
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.3937.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.3937 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.3327 | 0.4867 | +0.15 | +46.29% |
| Apr 27, 2026 | Mar 31, 2026 | 0.1926 | 0.153 | -0.04 | -20.56% |
| Feb 4, 2026 | Dec 31, 2025 | 0.2931 | 0.3576 | +0.06 | +22.01% |
| Oct 30, 2025 | Sep 30, 2025 | 0.2015 | 0.2989 | +0.10 | +48.34% |
| Jul 30, 2025 | Jun 30, 2025 | 0.1379 | 0.2652 | +0.13 | +92.31% |
News
Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer 
These Analysts Boost Their Forecasts On Vir Biotechnology 
Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why 
Why Is Monte Rosa Stock Trading Higher Today? 
Why Is Taysha Gene Therapies Stock Falling Friday? 
Stocks That Hit 52-Week Highs On Tuesday
Your note
Sign in to keep a note on ALPMF — it syncs with the Stock Master app.